Incidence of non-Alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy

Journal of Hepatology

Volumn 62, Issue 1, 2015, Pages 182-189

  Wong, Vincent Wai Sun ^a   Wong, Grace Lai Hung ^a   Yeung, David Ka Wai ^a   Lau, Tina Kit Ting ^a   Chan, Carmen Ka Man ^a   Chim, Angel Mei Ling ^a   Abrigo, Jill M ^a   Chan, Ruth Suk Mei ^a   Woo, Jean ^a   Tse, Yee Kit ^a   Chu, Winnie Chiu Wing ^a   Chan, Henry Lik Yuen ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Asians; Fibroscan; Liver fibrosis; Non Alcoholic steatohepatitis; Obesity

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; ELASTOGRAPH; ELASTOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HONG KONG; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID LIVER LEVEL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; POPULATION RESEARCH; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; RIGIDITY; STEATOSIS; CROSS-SECTIONAL STUDY; HEALTH SURVEY; INCIDENCE; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES;

CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; INCIDENCE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES;

EID: 84918504185     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.041     Document Type: Article

References (38)

1. C.D. Williams, J. Stengel, M.I. Asike, D.M. Torres, J. Shaw, and M. Contreras Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-Aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 2011 124 131
2. V.W. Wong, W.C. Chu, G.L. Wong, R.S. Chan, A.M. Chim, and A. Ong Prevalence of non-Alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography Gut 61 2012 409 415
3. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, and P. Carucci Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
4. V. Ratziu, L. Bonyhay, V. Di Martino, F. Charlotte, L. Cavallaro, and M.H. Sayegh-Tainturier Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis Hepatology 35 2002 1485 1493
5. V.W. Wong, G.L. Wong, P.C. Choi, A.W. Chan, M.K. Li, and H.Y. Chan Disease progression of non-Alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years Gut 59 2010 969 974
6. M.R. Charlton, J.M. Burns, R.A. Pedersen, K.D. Watt, J.K. Heimbach, and R.A. Dierkhising Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States Gastroenterology 141 2011 1249 1253
7. M. Hamaguchi, T. Kojima, N. Takeda, T. Nakagawa, H. Taniguchi, and K. Fujii The metabolic syndrome as a predictor of nonalcoholic fatty liver disease Ann Intern Med 143 2005 722 728
8. G. Bedogni, L. Miglioli, F. Masutti, A. Castiglione, L.S. Croce, and C. Tiribelli Incidence and natural course of fatty liver in the general population: the Dionysos study Hepatology 46 2007 1387 1391
9. A. Tsuneto, A. Hida, N. Sera, M. Imaizumi, S. Ichimaru, and E. Nakashima Fatty liver incidence and predictive variables Hypertens Res 33 2010 638 643
10. S. Zelber-Sagi, R. Lotan, A. Shlomai, M. Webb, G. Harrari, and A. Buch Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up J Hepatol 56 2012 1145 1151
11. K.C. Sung, S.H. Wild, and C.D. Byrne Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension J Hepatol 60 2014 1040 1045
12. S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, and M. Hurley The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 2002 745 750
13. S. McPherson, J.R. Jonsson, G.J. Cowin, P. O'Rourke, A.D. Clouston, and A. Volp Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered J Hepatol 51 2009 389 397
14. S.S. Lee, S.H. Park, H.J. Kim, S.Y. Kim, M.Y. Kim, and D.Y. Kim Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations J Hepatol 52 2010 579 585
15. M. Noureddin, J. Lam, M.R. Peterson, M. Middleton, G. Hamilton, and T.A. Le Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials Hepatology 58 2013 1930 1940
16. R. Kwok, Y.K. Tse, G.L. Wong, Y. Ha, A.U. Lee, and M.C. Ngu Systematic review with meta-Analysis: non-invasive assessment of non-Alcoholic fatty liver disease - The role of transient elastography and plasma cytokeratin-18 fragments Aliment Pharmacol Ther 39 2014 254 269
17. V.W. Wong, J. Vergniol, G.L. Wong, J. Foucher, H.L. Chan, and B. Le Bail Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease Hepatology 51 2010 454 462
18. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
19. Y. Rotman, C. Koh, J.M. Zmuda, D.E. Kleiner, T.J. Liang, and C.R.N. Nash The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease Hepatology 52 2010 894 903
20. N. Santoro, R. Kursawe, E. D'Adamo, D.J. Dykas, C.K. Zhang, and A.E. Bale A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents Hepatology 52 2010 1281 1290
21. E.K. Speliotes, J.L. Butler, C.D. Palmer, B.F. Voight, G. Consortium, and M.I. Consortium PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease Hepatology 52 2010 904 912
22. L. Valenti, A. Alisi, E. Galmozzi, A. Bartuli, B. Del Menico, and A. Alterio I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease Hepatology 52 2010 1274 1280
23. J. Shen, G.L. Wong, H.L. Chan, H.Y. Chan, D.K. Yeung, and R.S. Chan PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome Aliment Pharmacol Ther 39 2014 532 539
24. V.W. Wong, G.L. Wong, W.C. Chu, A.M. Chim, A. Ong, and D.K. Yeung Hepatitis B virus infection and fatty liver in the general population J Hepatol 56 2012 533 540
25. V.W. Wong, R.S. Chan, G.L. Wong, B.H. Cheung, W.C. Chu, and D.K. Yeung Community-based lifestyle modification programme for non-Alcoholic fatty liver disease: a randomized controlled trial J Hepatol 59 2013 536 542
26. G.C. Farrell, S. Chitturi, G.K. Lau, J.D. Sollano Asia-Pacific Working Party on N Guidelines for the assessment and management of non-Alcoholic fatty liver disease in the Asia-Pacific region: executive summary J Gastroenterol Hepatol 22 2007 775 777
27. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, and K.A. Donato Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
28. J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, and J.C. Cohen Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
29. C.J. Liu Prevalence and risk factors for non-Alcoholic fatty liver disease in Asian people who are not obese J Gastroenterol Hepatol 27 2012 1555 1560
30. K. Promrat, D.E. Kleiner, H.M. Niemeier, E. Jackvony, M. Kearns, and J.R. Wands Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis Hepatology 51 2010 121 129
31. G.L. Wong, V.W. Wong, P.C. Choi, A.W. Chan, A.M. Chim, and K.K. Yiu Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B Gut 58 2009 111 117
32. G.L. Wong, H.L. Chan, Z. Yu, A.W. Chan, P.C. Choi, and A.M. Chim Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B - A prospective cohort study with paired transient elastography examinations Aliment Pharmacol Ther 39 2014 883 893
33. M.W. Yu, W.L. Shih, C.L. Lin, C.J. Liu, J.W. Jian, and K.S. Tsai Body-mass index and progression of hepatitis B: a population-based cohort study in men J Clin Oncol 26 2008 5576 5582
34. E. Ishibashi, Y. Eguchi, T. Eguchi, A. Matsunobu, N. Oza, and S. Nakashita Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-Alcoholic fatty liver disease, but not in females J Gastroenterol Hepatol 23 2008 908 913
35. B.J. Park, Y.J. Kim, D.H. Kim, W. Kim, Y.J. Jung, and J.H. Yoon Visceral adipose tissue area is an independent risk factor for hepatic steatosis J Gastroenterol Hepatol 23 2008 900 907
36. P. Mofrad, M.J. Contos, M. Haque, C. Sargeant, R.A. Fisher, and V.A. Luketic Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values Hepatology 37 2003 1286 1292
37. V.W. Wong, G.L. Wong, S.W. Tsang, A.Y. Hui, A.W. Chan, and P.C. Choi Metabolic and histological features of non-Alcoholic fatty liver disease patients with different serum alanine aminotransferase levels Aliment Pharmacol Ther 29 2009 387 396
38. V.W. Wong, A.Y. Hui, S.W. Tsang, J.L. Chan, A.M. Tse, and K.F. Chan Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 4 2006 1154 1161